California Residency Program Collaborative
Sponsored by California Academy of Family Physicians and CAFP Foundation
The overall goal of this collaborative is to improve education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. We will enhance training for resident and faculty physicians while encouraging creative and innovative approaches to meet program and community needs. Projects will identify methods to improve or advance the standard of care for patients, demonstrate how best to implement those methods, and evaluate the outcomes of these efforts. We will reach Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, ObGyn and Psychiatry residencies.
Our grantees’ projects will:
Our expectation is that residency program applicants have an identified need(s), a methodology to both implement the action plan and measure the project’s impact, and a timeline for spread and plan for sustainability. Collaboration and communication with other stakeholders, including community members, is also encouraged and should be outlined in the proposal.
Our 16 residency programs will work for a little over a year on their projects and during that time will also work as a collaborative – meeting to share resources, wins, challenges and results. They will participate in face-to-face meetings, webinars and check-in calls, and will present a final report in July 2022.
More than 10 Activities in Homeroom including:
New HHS Practice Guidelines FAQs
Prescribers no longer need to complete the MAT training for the 30-patient limit. Read More
New Requirements for Buprenorphine X-Waiver US Department of Health and Human Services (HHS) has released new practice guidelines for treatment of opioid use disorder. HHS has officially removed the X-waiver training requirement to treat patients with buprenorphine." Download PDF: xWaiver Training HHS ruling
Since late 2009, working with 13 other organizations to ensure that the Food and Drug Administration’s REMS (Risk Evaluation and Mitigation Strategy) for extended-release/long-acting opioids would be implemented in a manner that supports quality education and provider support. CO*RE has been instrumental in providing live, online and enduring education, plus tools and resources to more than 750,000 prescribers during the past five years.
This website will be continually updated with information to assist these and other residency programs that strive to make improvements in order to better serve their patients with SUD. Please check back as we post education, tools and resources on this website throughout the collaboration.
Taking the latest research and sharing insights from clinicians about implementing it in clinical practice, Science to Medicine features real-world examples from a variety of practice settings and clinician types—operationalizing research to improve patient care.
Family Physicians can help destigmatize the disease of addiction by setting an example!
If you have questions, please direct them in writing to Jerri Davis, firstname.lastname@example.org.